Issue Date: June 2, 2014 | Web Date: May 30, 2014
Human Proteome Map Assembled
A map of the human genome has existed for more than a decade. A similar map of the proteome—the complete catalog of proteins encoded by the genome—has not been assembled, although many of the pieces have been available.
The wait is now over. Two independent teams have assembled draft maps of the human proteome that they will make publicly available.
One team, led by Akhilesh Pandey of Johns Hopkins University School of Medicine in collaboration with the Institute of Bioinformatics, in Bangalore, India, performed high-resolution mass spectrometric analysis of 30 normal human tissues (Nature 2014, DOI: 10.1038/nature13302). They identified proteins encoded by 17,294 genes.
Another team, led by Bernhard Kuster of the Technical University of Munich, in Germany, combined new mass spectrometric analyses of 60 tissues, 13 body fluids, and 147 cell lines with data already available in the literature (Nature 2014, DOI: 10.1038/nature13319). They found evidence for 18,097 proteins.
The proteins the teams found account for 80–90% of those predicted to exist. The biggest gap is in the class of proteins known as G protein-coupled receptors, or GPCRs. Many of these missing GPCRs are thought to be involved in taste and smell perception. Kuster says many of them may be evolutionary remnants that are no longer needed and thus not actually produced.
Both studies included some surprises. For example, Pandey’s group found several proteins that are coded by previously assumed noncoding RNAs. “Clearly at least a subset of these noncoding RNAs are translated,” Pandey says. Kuster’s analysis likewise traced some proteins back to sequences thought to be noncoding RNAs.
Kuster’s study identified a “core proteome” that consists of a large number of proteins that are found in all tissues. That finding led to another surprise: “The number of organ-specific proteins is really small,” he says.
“I guess this means the human proteome project is basically done, and it didn’t take a billion dollars as people predicted,” says John R. Yates III, a proteomics expert at Scripps Research Institute California who was not involved with either study. “In general, the first 90% of projects like these are the easy part, and the last 10% are the really hard and expensive part.”
Pandey and Kuster both say their maps will remain drafts for the foreseeable future. “The proteome is dynamic. We always get a freeze-frame picture,” Pandey says.
“We may never be able to claim completeness—and perhaps we don’t really have to,” Kuster says.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society